Skip to main content
PMHS logo

PMHS · Polomar Health Services, Inc. · Metrics

Track PMHS — free
$0.12 +0.00 (+0.00%) At close · Oct 5
Market Cap
$4.82M
Shares
28.38M
Volume · Oct 5 33.26K Avg daily vol (3M) 14.92K

PMHS metrics

38 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.12
Market cap
$4.82M

Price action

20 metrics
Price change (1W)
-29.4%
Price change (30D)
-40.0%
Price change (3M)
+1.7%
Price change (6M)
-25.0%
Price change (YTD)
-85.0%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
45.1
Price vs SMA 50
-28.2%
Price vs SMA 200
—
Avg volume (3M)
14,921
Relative volume
2.2
Average dollar volume
$2,681

Company

3 metrics
Sector
Healthcare
Industry
Pharmaceutical Retailers
Shares outstanding
28.38M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 65.8%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-196.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
61.1%
Operating margin
-295.0%
Trailing 12 months
Net margin
-298.3%
Gross profit (TTM)
$1.94M
Operating profit (TTM)
−$9.36M
Net income (TTM)
−$9.46M
Trailing 12 months
Diluted EPS (TTM)
$-0.35
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.04

Growth

11 metrics
Revenue growth YoY
+27,847.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.17M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.4%
Year over year · more shares
Revenue CAGR (3Y)
+165.8%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-1,161.6%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
−$85,970
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-90.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$87,818
Total assets
$814,726
Total debt
$33,849

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6,956
Capital expenditures (TTM)
$90,893
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1265521 CUSIP 898391206 Visit website Investor relations